Access Resources
5171 - 5180 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Gene Therapy Strategies to Restore ER Proteostasis in DiseaseJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 26Issue #: 6Start Page: 1404End Page: 1413Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ymthe.2018.04.004Best OA location URL: https://doi.org/10.1016/j.ymthe.2018.04.004Citation Count: 34
- Genetic disruption of the nuclear receptor Nur77 (Nr4a1) in rat reduces dopamine cell loss and l-Dopa-induced dyskinesia in experimental Parkinson's disease2018RESTRICTEDTitle: Genetic disruption of the nuclear receptor Nur77 (Nr4a1) in rat reduces dopamine cell loss and l-Dopa-induced dyskinesia in experimental Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 304Issue #:Start Page: 143End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.03.008Citation Count: 25
- Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?2018RESTRICTEDTitle: Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?Journal Name: ToxiconPublisher: Elsevier BVVol: 147Issue #:Start Page: 89End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.toxicon.2017.09.004Best OA location URL: https://europepmc.org/articles/pmc5839920?pdf=renderCitation Count: 44
-
RESTRICTEDTitle: mGlu4 allosteric modulation for treating Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 135Issue #:Start Page: 308End Page: 315Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.03.027Citation Count: 25
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study2018RESTRICTEDTitle: Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 17Issue #: 6Start Page: 548End Page: 558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30126-1Best OA location URL: http://www.thelancet.com/article/S1474442218301261/pdfCitation Count: 94
- Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort2018RESTRICTEDTitle: Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 51Issue #:Start Page: 49End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.047Citation Count: 60
-
RESTRICTEDTitle: The nosology of tardive syndromesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 389Issue #:Start Page: 10End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2018.02.008Citation Count: 59
-
RESTRICTEDTitle: The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 51Issue #:Start Page: 9End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.001Citation Count: 102
-
RESTRICTEDTitle: Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 51Issue #:Start Page: 67End Page: 72Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.044Citation Count: 17
-
RESTRICTEDTitle: Immunosuppressants and risk of Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 7Start Page: 870End Page: 875Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.580Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.580Citation Count: 62